English

CytoCore, Inc.

EDGAR

Quarterly report (10-Q) · filed 2003-11-04

15 filing records in this dataset, filed from 2000-09-08 to 2003-11-04. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.46 million USD

2003-09-30 · USD

Exact inputs and evidence

Revenue: 1464000 USD Source

Operating margin

-413.46%

2003-09-30 · %

Exact inputs and evidence

Operating Income: -6053000 USD Source
Revenue: 1464000 USD Source

Operating cash flow

-5.58 million USD

2003-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -12743000 USD Source
Operating Cash Flow: -7159000 USD Source

Free cash flow

-6.72 million USD

2003-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -12743000 USD Source
Operating Cash Flow: -7159000 USD Source
Capital Expenditure: 3098000 USD Source
Capital Expenditure: 1965000 USD Source

Cash and cash equivalents: 7.64 million USD 2003-09-30 Source
Exact value

7637000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

8.4 million USD

2002-10-01 – 2003-09-30

Exact inputs and evidence

Revenue: 7927000 USD · 2002-01-01 – 2002-12-31 Source
Revenue: 5652000 USD · 2002-01-01 – 2002-09-30 Source
Revenue: 3163000 USD · 2003-01-01 – 2003-03-31 Source
Revenue: 1494000 USD · 2003-04-01 – 2003-06-30 Source
Revenue: 1464000 USD · 2003-07-01 – 2003-09-30 Source

Net income

-18 million USD

2002-10-01 – 2003-09-30

Exact inputs and evidence

Net income: -17443000 USD · 2002-01-01 – 2002-12-31 Source
Net income: -13463000 USD · 2002-01-01 – 2002-09-30 Source
Net income: -3284000 USD · 2003-01-01 – 2003-03-31 Source
Net income: -5040000 USD · 2003-04-01 – 2003-06-30 Source
Net income: -5707000 USD · 2003-07-01 – 2003-09-30 Source

Operating cash flow

-16.4 million USD

2002-10-01 – 2003-09-30

Exact inputs and evidence

Operating cash flow: -10044000 USD · 2002-01-01 – 2002-12-31 Source
Operating cash flow: -6357000 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -3426000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: -7159000 USD · 2003-01-01 – 2003-06-30 Source
Operating cash flow: -3426000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: -12743000 USD · 2003-01-01 – 2003-09-30 Source
Operating cash flow: -7159000 USD · 2003-01-01 – 2003-06-30 Source

Capital expenditure

3.86 million USD

2002-10-01 – 2003-09-30

Exact inputs and evidence

Capital expenditure: 12568000 USD · 2002-01-01 – 2002-12-31 Source
Capital expenditure: 11802000 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 737000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 1965000 USD · 2003-01-01 – 2003-06-30 Source
Capital expenditure: 737000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 3098000 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 1965000 USD · 2003-01-01 – 2003-06-30 Source

Free cash flow

-20.3 million USD

2002-10-01 – 2003-09-30

Exact inputs and evidence

Operating cash flow: -10044000 USD · 2002-01-01 – 2002-12-31 Source
Operating cash flow: -6357000 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -3426000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: -7159000 USD · 2003-01-01 – 2003-06-30 Source
Operating cash flow: -3426000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: -12743000 USD · 2003-01-01 – 2003-09-30 Source
Operating cash flow: -7159000 USD · 2003-01-01 – 2003-06-30 Source
Capital expenditure: 12568000 USD · 2002-01-01 – 2002-12-31 Source
Capital expenditure: 11802000 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 737000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 1965000 USD · 2003-01-01 – 2003-06-30 Source
Capital expenditure: 737000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 3098000 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 1965000 USD · 2003-01-01 – 2003-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-11-04.

Financial data available through: 2002-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2002-12-31
Operating income: 5 of 11 periods available· newest 2002-12-31
Net income: 5 of 11 periods available· newest 2002-12-31
Operating cash flow: 5 of 11 periods available· newest 2002-12-31
Capital expenditure: 5 of 11 periods available· newest 2002-12-31
Total assets: 4 of 11 periods available· newest 2002-12-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 2002-12-31
Current liabilities: 4 of 11 periods available· newest 2002-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2002-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+119.4%

Prior period

USD 3.61 million

2001-01-01 – 2001-12-31
Current period

USD 7.93 million

2002-01-01 – 2002-12-31

Exact inputs and evidence

7927000 − 3613000 = 4314000 USD

3613000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
7927000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CytoCore, Inc. · 2002-12-31 CytoCore, Inc. (edgar:1111312) Year-over-year change in Revenue: 4314000 USD Concept: fundies:Revenue Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 7927000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#8874 Input fundies:Revenue: 3613000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#8874
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 4.21 million

Prior period

−USD 13.23 million

2001-01-01 – 2001-12-31
Current period

−USD 17.44 million

2002-01-01 – 2002-12-31

Exact inputs and evidence

-17443000 − -13230000 = -4213000 USD

-13230000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
-17443000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CytoCore, Inc. · 2002-12-31 CytoCore, Inc. (edgar:1111312) Year-over-year change in Net income: -4213000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -17443000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12262 Input fundies:NetIncome: -13230000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12262
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 3.44 million

Prior period

−USD 6.61 million

2001-01-01 – 2001-12-31
Current period

−USD 10.04 million

2002-01-01 – 2002-12-31

Exact inputs and evidence

-10044000 − -6605000 = -3439000 USD

-6605000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
-10044000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CytoCore, Inc. · 2002-12-31 CytoCore, Inc. (edgar:1111312) Year-over-year change in Operating cash flow: -3439000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -10044000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12596 Input fundies:OperatingCashFlow: -6605000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12596
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+295.2%

Prior period

USD 3.18 million

2001-01-01 – 2001-12-31
Current period

USD 12.57 million

2002-01-01 – 2002-12-31

Exact inputs and evidence

12568000 − 3180000 = 9388000 USD

3180000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
12568000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CytoCore, Inc. · 2002-12-31 CytoCore, Inc. (edgar:1111312) Year-over-year change in Capital expenditure: 9388000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 12568000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12655 Input fundies:CapitalExpenditure: 3180000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12655
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2002 2002-01-01 – 2002-12-31

Revenue USD 7.93 million 100% of revenue
Operating costs Derived USD 28.03 million 354% of revenue
Operating income −USD 20.11 million −254% of revenue
Tax, interest and other Derived −USD 2.66 million −34% of revenue
Net income −USD 17.44 million −220% of revenue

Cash

Operating cash flow −USD 10.04 million −127% of revenue
Capital expenditure USD 12.57 million 159% of revenue
Free cash flow Derived −USD 22.61 million −285% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Operating loss: operating costs were 176% of revenue.
1999 Operating loss: operating costs were 240% of revenue.
2000 Operating loss: operating costs were 725% of revenue.
2001 Operating loss: operating costs were 612% of revenue.
2002 Operating loss: operating costs were 354% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	2590000	4558000 Derived	-1968000	-101000 Derived	-1867000	-2647000 Derived	Source 1998-01-01 – 1998-12-31: 2590000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -1968000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -1867000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -2638000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 9000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	2592000	6226000 Derived	-3634000	-258000 Derived	-3376000	-3370000 Derived	Source 1999-01-01 – 1999-12-31: 2592000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -3634000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -3376000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -3188000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 182000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	2693000	19521000 Derived	-16828000	-3269000 Derived	-13559000	-3432000 Derived	Source 2000-01-01 – 2000-12-31: 2693000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -16828000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -13559000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -2867000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 565000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	3613000	22101000 Derived	-18488000	-5258000 Derived	-13230000	-9785000 Derived	Source 2001-01-01 – 2001-12-31: 3613000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -18488000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -13230000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -6605000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 3180000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	7927000	28034000 Derived	-20107000	-2664000 Derived	-17443000	-22612000 Derived	Source 2002-01-01 – 2002-12-31: 7927000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -20107000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -17443000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -10044000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 12568000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 7.9M 2002

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	2590000	Revenue: 2590000 Open source
19991999-12-31	Revenue	2592000	Revenue: 2592000 Open source
20002000-12-31	Revenue	2693000	Revenue: 2693000 Open source
20012001-12-31	Revenue	3613000	Revenue: 3613000 Open source
20022002-12-31	Revenue	7927000	Revenue: 7927000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

119.4% 2002

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	No prior comparable period	Revenue: 2590000 Open source
19991999-12-31	Year over year	0.1%	Revenue: 2592000 Open source Revenue: 2590000 Open source
20002000-12-31	Year over year	3.9%	Revenue: 2693000 Open source Revenue: 2592000 Open source
20012001-12-31	Year over year	34.2%	Revenue: 3613000 Open source Revenue: 2693000 Open source
20022002-12-31	Year over year	119.4%	Revenue: 7927000 Open source Revenue: 3613000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -253.7% 2002

Net margin -220% 2002

Free cash flow margin -285.3% 2002

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	-76%	Operating Income: -1968000 Open source Revenue: 2590000 Open source
19991999-12-31	Operating margin	-140.2%	Operating Income: -3634000 Open source Revenue: 2592000 Open source
20002000-12-31	Operating margin	-624.9%	Operating Income: -16828000 Open source Revenue: 2693000 Open source
20012001-12-31	Operating margin	-511.7%	Operating Income: -18488000 Open source Revenue: 3613000 Open source
20022002-12-31	Operating margin	-253.7%	Operating Income: -20107000 Open source Revenue: 7927000 Open source
19981998-12-31	Net margin	-72.1%	Net Income: -1867000 Open source Revenue: 2590000 Open source
19991999-12-31	Net margin	-130.2%	Net Income: -3376000 Open source Revenue: 2592000 Open source
20002000-12-31	Net margin	-503.5%	Net Income: -13559000 Open source Revenue: 2693000 Open source
20012001-12-31	Net margin	-366.2%	Net Income: -13230000 Open source Revenue: 3613000 Open source
20022002-12-31	Net margin	-220%	Net Income: -17443000 Open source Revenue: 7927000 Open source
19981998-12-31	Free cash flow margin	-102.2%	Revenue: 2590000 Open source Operating Cash Flow: -2638000 Open source Capital Expenditure: 9000 Open source
19991999-12-31	Free cash flow margin	-130%	Revenue: 2592000 Open source Operating Cash Flow: -3188000 Open source Capital Expenditure: 182000 Open source
20002000-12-31	Free cash flow margin	-127.4%	Revenue: 2693000 Open source Operating Cash Flow: -2867000 Open source Capital Expenditure: 565000 Open source
20012001-12-31	Free cash flow margin	-270.8%	Revenue: 3613000 Open source Operating Cash Flow: -6605000 Open source Capital Expenditure: 3180000 Open source
20022002-12-31	Free cash flow margin	-285.3%	Revenue: 7927000 Open source Operating Cash Flow: -10044000 Open source Capital Expenditure: 12568000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -10M 2002

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	-2638000	Operating Cash Flow: -2638000 Open source
19991999-12-31	Operating cash flow	-3188000	Operating Cash Flow: -3188000 Open source
20002000-12-31	Operating cash flow	-2867000	Operating Cash Flow: -2867000 Open source
20012001-12-31	Operating cash flow	-6605000	Operating Cash Flow: -6605000 Open source
20022002-12-31	Operating cash flow	-10044000	Operating Cash Flow: -10044000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -22.6M 2002

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	-2647000	Operating Cash Flow: -2638000 Open source Capital Expenditure: 9000 Open source
19991999-12-31	Free cash flow	-3370000	Operating Cash Flow: -3188000 Open source Capital Expenditure: 182000 Open source
20002000-12-31	Free cash flow	-3432000	Operating Cash Flow: -2867000 Open source Capital Expenditure: 565000 Open source
20012001-12-31	Free cash flow	-9785000	Operating Cash Flow: -6605000 Open source Capital Expenditure: 3180000 Open source
20022002-12-31	Free cash flow	-22612000	Operating Cash Flow: -10044000 Open source Capital Expenditure: 12568000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	No source recorded
1999-12-31	Liabilities / assets	Not reported	Total Assets: 5938000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 94874000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 90682000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 79971000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

13.87× 2002

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Current assets / current liabilities	Not reported	No source recorded
19991999-12-31	Current assets / current liabilities	4.65×	Current Assets: 4109000 Open source Current Liabilities: 884000 Open source
20002000-12-31	Current assets / current liabilities	49.85×	Current Assets: 92419000 Open source Current Liabilities: 1854000 Open source
20012001-12-31	Current assets / current liabilities	19.68×	Current Assets: 84010000 Open source Current Liabilities: 4268000 Open source
20022002-12-31	Current assets / current liabilities	13.87×	Current Assets: 52489000 Open source Current Liabilities: 3785000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	−USD 1.87 million Exact value Exact value: -1867000 USD 1998-01-01 – 1998-12-31: -1867000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore, Inc. · 1998-12-31 CytoCore, Inc. (edgar:1111312) Net Income: -1867000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1867000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0001095811-01-001646.txt#2381 The citation records this snapshot. The page link may show a newer release later.	−USD 2.64 million Exact value Exact value: -2638000 USD 1998-01-01 – 1998-12-31: -2638000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore, Inc. · 1998-12-31 CytoCore, Inc. (edgar:1111312) Operating Cash Flow: -2638000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2638000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0001095811-01-001646.txt#2397 The citation records this snapshot. The page link may show a newer release later.	USD 9,000 Exact value Exact value: 9000 USD 1998-01-01 – 1998-12-31: 9000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CytoCore, Inc. · 1998-12-31 CytoCore, Inc. (edgar:1111312) Capital Expenditure: 9000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0001095811-01-001646.txt#2399 The citation records this snapshot. The page link may show a newer release later.	−USD 2.65 million Calculation and evidence -2638000 − 9000 USD Exact free cash flow: -2647000 USD 1998-01-01 – 1998-12-31: -2638000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 9000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CytoCore, Inc. · 1998-12-31 CytoCore, Inc. (edgar:1111312) Free cash flow: -2647000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2638000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0001095811-01-001646.txt#2397 Input fundies:CapitalExpenditure: 9000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0001095811-01-001646.txt#2399 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 3.38 million Exact value Exact value: -3376000 USD 1999-01-01 – 1999-12-31: -3376000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore, Inc. · 1999-12-31 CytoCore, Inc. (edgar:1111312) Net Income: -3376000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3376000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-02-000186.txt#10499 The citation records this snapshot. The page link may show a newer release later.	−USD 3.19 million Exact value Exact value: -3188000 USD 1999-01-01 – 1999-12-31: -3188000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore, Inc. · 1999-12-31 CytoCore, Inc. (edgar:1111312) Operating Cash Flow: -3188000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3188000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-02-000186.txt#10812 The citation records this snapshot. The page link may show a newer release later.	USD 182,000 Exact value Exact value: 182000 USD 1999-01-01 – 1999-12-31: 182000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CytoCore, Inc. · 1999-12-31 CytoCore, Inc. (edgar:1111312) Capital Expenditure: 182000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 182000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-02-000186.txt#10855 The citation records this snapshot. The page link may show a newer release later.	−USD 3.37 million Calculation and evidence -3188000 − 182000 USD Exact free cash flow: -3370000 USD 1999-01-01 – 1999-12-31: -3188000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 182000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CytoCore, Inc. · 1999-12-31 CytoCore, Inc. (edgar:1111312) Free cash flow: -3370000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3188000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-02-000186.txt#10812 Input fundies:CapitalExpenditure: 182000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-02-000186.txt#10855 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 13.56 million Exact value Exact value: -13559000 USD 2000-01-01 – 2000-12-31: -13559000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore, Inc. · 2000-12-31 CytoCore, Inc. (edgar:1111312) Net Income: -13559000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13559000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12262 The citation records this snapshot. The page link may show a newer release later.	−USD 2.87 million Exact value Exact value: -2867000 USD 2000-01-01 – 2000-12-31: -2867000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore, Inc. · 2000-12-31 CytoCore, Inc. (edgar:1111312) Operating Cash Flow: -2867000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2867000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12596 The citation records this snapshot. The page link may show a newer release later.	USD 565,000 Exact value Exact value: 565000 USD 2000-01-01 – 2000-12-31: 565000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CytoCore, Inc. · 2000-12-31 CytoCore, Inc. (edgar:1111312) Capital Expenditure: 565000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 565000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12655 The citation records this snapshot. The page link may show a newer release later.	−USD 3.43 million Calculation and evidence -2867000 − 565000 USD Exact free cash flow: -3432000 USD 2000-01-01 – 2000-12-31: -2867000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 565000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CytoCore, Inc. · 2000-12-31 CytoCore, Inc. (edgar:1111312) Free cash flow: -3432000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2867000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12596 Input fundies:CapitalExpenditure: 565000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12655 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 13.23 million Exact value Exact value: -13230000 USD 2001-01-01 – 2001-12-31: -13230000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore, Inc. · 2001-12-31 CytoCore, Inc. (edgar:1111312) Net Income: -13230000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13230000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12262 The citation records this snapshot. The page link may show a newer release later.	−USD 6.61 million Exact value Exact value: -6605000 USD 2001-01-01 – 2001-12-31: -6605000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore, Inc. · 2001-12-31 CytoCore, Inc. (edgar:1111312) Operating Cash Flow: -6605000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6605000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12596 The citation records this snapshot. The page link may show a newer release later.	USD 3.18 million Exact value Exact value: 3180000 USD 2001-01-01 – 2001-12-31: 3180000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CytoCore, Inc. · 2001-12-31 CytoCore, Inc. (edgar:1111312) Capital Expenditure: 3180000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3180000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12655 The citation records this snapshot. The page link may show a newer release later.	−USD 9.79 million Calculation and evidence -6605000 − 3180000 USD Exact free cash flow: -9785000 USD 2001-01-01 – 2001-12-31: -6605000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 3180000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CytoCore, Inc. · 2001-12-31 CytoCore, Inc. (edgar:1111312) Free cash flow: -9785000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6605000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12596 Input fundies:CapitalExpenditure: 3180000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12655 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 17.44 million Exact value Exact value: -17443000 USD 2002-01-01 – 2002-12-31: -17443000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore, Inc. · 2002-12-31 CytoCore, Inc. (edgar:1111312) Net Income: -17443000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17443000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12262 The citation records this snapshot. The page link may show a newer release later.	−USD 10.04 million Exact value Exact value: -10044000 USD 2002-01-01 – 2002-12-31: -10044000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore, Inc. · 2002-12-31 CytoCore, Inc. (edgar:1111312) Operating Cash Flow: -10044000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10044000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12596 The citation records this snapshot. The page link may show a newer release later.	USD 12.57 million Exact value Exact value: 12568000 USD 2002-01-01 – 2002-12-31: 12568000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CytoCore, Inc. · 2002-12-31 CytoCore, Inc. (edgar:1111312) Capital Expenditure: 12568000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12568000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12655 The citation records this snapshot. The page link may show a newer release later.	−USD 22.61 million Calculation and evidence -10044000 − 12568000 USD Exact free cash flow: -22612000 USD 2002-01-01 – 2002-12-31: -10044000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 12568000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CytoCore, Inc. · 2002-12-31 CytoCore, Inc. (edgar:1111312) Free cash flow: -22612000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T15:00:50Z Snapshot: ef79bfe8433c5cb2ec0599480f8a7c42edb903586724c6dfb1747bd56f838e56 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1111312?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10044000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12596 Input fundies:CapitalExpenditure: 12568000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1111312/0000936392-03-000217.txt#12655 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

15 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001111312, 1111312, edgar:1111312

Also known as APPLIED MOLECULAR EVOLUTION INC

CytoCore, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2002 2002-01-01 – 2002-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation